Research Topics
Genomes and Genes | Stuart H RalstonSummaryAffiliation: University of Edinburgh Country: UK Publications
| Collaborators
|
Detail Information
Publications
Pathogenesis of Paget disease of boneStuart H Ralston
Rheumatic Diseases Unit, Molecular Medicine Centre, Western General Hospital, University of Edinburgh, Edinburgh EH4 2XU, UK
Calcif Tissue Int 91:97-113. 2012....
Generation Scotland: the Scottish Family Health Study; a new resource for researching genes and heritabilityBlair H Smith
University of Aberdeen, Department of General Practice and Primary Care, Foresterhill Health Centre, Westburn Road, Aberdeen, UK
BMC Med Genet 7:74. 2006....
Protocol for stage 2 of the GaP study (genetic testing acceptability for Paget's disease of bone): a questionnaire study to investigate whether relatives of people with Paget's disease would accept genetic testing and preventive treatment if they were avaAnne L Langston
Edinburgh Clinical Trials Unit, University of Edinburgh, Queens Medical Research Institute, Room E1, 16, 47 Little France Crescent, Edinburgh, EH16 4TJ, UK
BMC Health Serv Res 8:116. 2008..Illness representations are examined using Leventhal's Common Sense Self-Regulation Model while cognitions about treatment behaviours (acceptance of testing and treatment uptake) are conceptualised within the Theory of Planned Behaviour...
Protocol for stage 1 of the GaP study (Genetic testing acceptability for Paget's disease of bone): an interview study about genetic testing and preventive treatment: would relatives of people with Paget's disease want testing and treatment if they were avAnne L Langston
Health Services Research Unit, University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen, AB25 2ZD, UK
BMC Health Serv Res 6:71. 2006..The Theory of Planned Behaviour is a theoretical model that predicts behaviours from people's beliefs about the consequences, social pressures and perceived control over the behaviour, including uptake of treatment...
Pathogenesis of Paget's disease of boneStuart H Ralston
Rheumatic Diseases Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK
Bone 43:819-25. 2008....
Pathogenesis and management of Paget's disease of boneStuart H Ralston
Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK
Lancet 372:155-63. 2008..No firm evidence as yet exists to show that bisphosphonates can prevent the development of complications of Paget's disease of bone, and further work is needed to address the effects of treatment on long-term clinical outcome...
Genetic determinants of osteoporosisStuart H Ralston
Department of Rheumatology, Rheumatic Diseases Unit, Edinburgh University Western General Hospital, Edinburgh, United Kingdom
Curr Opin Rheumatol 17:475-9. 2005..Several advances have been made over recent years in understanding the genetic basis of susceptibility to osteoporosis. This paper will review recent developments in this area...
Genetics of osteoporosisStuart H Ralston
Molecular Medicine Centre, Rheumatic Diseases Unit, Edinburgh University, Western General Hospital, Edinburgh EH4 2XU, UK
Proc Nutr Soc 66:158-65. 2007....
Loci for regulation of bone mineral density in men and women identified by genome wide linkage scan: the FAMOS studyStuart H Ralston
Rheumatic Diseases Unit, University of Edinburgh Western General Hospital, Crewe Road, Edinburgh EH4 2XU, Scotland, UK
Hum Mol Genet 14:943-51. 2005..This study provides evidence for gender-specific, site-specific and age-specific QTL, which regulate BMD in humans, and illustrates the importance of conducting subgroup analysis to detect these loci...
Genetic regulation of bone mass and susceptibility to osteoporosisStuart H Ralston
Rheumatic Diseases Unit, Molecular Medicine Centre, Western General Hospital, Edinburgh EH4 2XU, United Kingdom
Genes Dev 20:2492-506. 2006....
Juvenile Paget's disease, familial expansile osteolysis and other genetic osteolytic disordersStuart H Ralston
Rheumatic Diseases Unit, Molecular Medicine Centre, University of Edinburgh, Edinburgh, UK
Best Pract Res Clin Rheumatol 22:101-11. 2008..Anecdotal reports indicate that osteoclast inhibitors such as bisphosphonates are effective for suppressing bone turnover and improving symptoms in these disorders, although the long-term effects on clinical outcomes are unclear...
Multicenter blinded analysis of RT-PCR detection methods for paramyxoviruses in relation to Paget's disease of boneStuart H Ralston
Rheumatic Diseases Unit, School of Molecular and Clinical Medicine, University of Edinburgh, Edinburgh, UK
J Bone Miner Res 22:569-77. 2007....
Genetics of osteoporosisStuart H Ralston
University of Edinburgh, Western General Hospital, Edinburgh, UK
Ann N Y Acad Sci 1192:181-9. 2010..Although there has been extensive progress in this area over the past 10 years, most of the genetic variants that regulate susceptibility to osteoporosis remain to be discovered...
Genetics of osteoporosisStuart H Ralston
Rheumatic Diseases Unit, Molecular Medicine Centre, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU, United Kingdom
Endocr Rev 31:629-62. 2010..Although there has been extensive progress in identifying the genes and loci that contribute to the regulation of BMD and fracture over the past 15 yr, most of the genetic variants that regulate these phenotypes remain to be discovered...
Genetic determinants of Paget's disease of boneStuart H Ralston
Rheumatic Diseases Unit, Molecular Medicine Centre, University of Edinburgh, United Kingdom
Ann N Y Acad Sci 1240:53-60. 2011..These increase the risk of PDB individually by 1.3- to 1.7-fold, but have combined effects that account for about 86% of the population-attributable risk of PDB in SQSTM1 negative patients...
Risk of upper gastrointestinal tract events in risedronate users switched to alendronateStuart H Ralston
Institute of Genetics and Molecular Medicine, Western General Hospital, University of Edinburgh, UK
Calcif Tissue Int 87:298-304. 2010..This could lead to reduced compliance and reduced therapeutic effectiveness, which might offset the cost savings of using the generic formulation...
Randomized trial of alendronate plus vitamin D3 versus standard care in osteoporotic postmenopausal women with vitamin D insufficiencyStuart H Ralston
Rheumatic Diseases Unit, Molecular Medicine Centre, Institute of Genetics and Molecular Medicine, Western General Hospital, University of Edinburgh, UK
Calcif Tissue Int 88:485-94. 2011....
Identification of novel biphenyl carboxylic acid derivatives as novel antiresorptive agents that do not impair parathyroid hormone-induced bone formationAymen I Idris
Rheumatic Diseases Unit, Molecular Medicine Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU, United Kingdom
Endocrinology 150:5-13. 2009....
Promoter and intron 1 polymorphisms of COL1A1 interact to regulate transcription and susceptibility to osteoporosisHuilin Jin
Rheumatic Diseases Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU, UK
Hum Mol Genet 18:2729-38. 2009..This is consistent with a model whereby increased COL1A1 transcription predisposes to osteoporosis, probably by increasing production of the alpha 1 chain and disrupting the normal ratio of collagen type 1 alpha 1 and alpha 2 chains...
Genome-wide association identifies three new susceptibility loci for Paget's disease of boneOmar M E Albagha
Rheumatic Diseases Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, UK
Nat Genet 43:685-9. 2011..40, P = 7.38 × 10(-17)) with PDB. These seven loci explained ∼13% of the familial risk of PDB. These studies provide new insights into the genetic architecture and pathophysiology of PDB...
The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivoAymen I Idris
Bone Research Group, Institute of Genetic and Molecular Medicine, Molecular Medicine Centre, University of Edinburgh, General Western Hospital, Edinburgh, EH4 2XU, UK
Bone 46:1089-99. 2010..We conclude that pharmacological blockade of TRPV1 ion channels by capsazepine inhibits osteoclastic bone resorption and protects against ovariectomy induced bone loss in mice, but also inhibits osteoblast activity and bone formation...
The type 2 cannabinoid receptor regulates bone mass and ovariectomy-induced bone loss by affecting osteoblast differentiation and bone formationAntonia Sophocleous
Rheumatic Diseases Unit, Molecular Medicine Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU, UK
Endocrinology 152:2141-9. 2011..These studies indicate that the CB2 regulates osteoblast differentiation in vitro and bone formation in vivo...
The biphenyl-carboxylate derivative ABD328 is a novel orally active antiresorptive agentAymen I Idris
Rheumatic Diseases Unit, Molecular Medicine Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, EH4 2XU, UK
Calcif Tissue Int 87:525-32. 2010..The results indicate that biphenyl carboxylates like ABD328 are oral candidate drugs for the treatment of diseases characterized by increased bone resorption, such as postmenopausal osteoporosis...
Haplotypes defined by promoter and intron 1 polymorphisms of the COLIA1 gene regulate bone mineral density in womenTracy L Stewart
Rheumatic Diseases Unit, Western General Hospital, Edinburgh EH4 2XU, United Kingdom
J Clin Endocrinol Metab 91:3575-83. 2006..The COLIA1 gene is a strong candidate for susceptibility to osteoporosis. The causal genetic variants are currently unclear, but the most likely are functional polymorphisms in the promoter and intron 1 of COLIA1...
Cannabinoid receptor type 1 protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cellsAymen I Idris
Rheumatic Diseases Unit, Molecular Medicine Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK
Cell Metab 10:139-47. 2009....
Small molecule inhibitors of IkappaB kinase signaling inhibit osteoclast formation in vitro and prevent ovariectomy-induced bone loss in vivoAymen I Idris
Institute of Genetic and Molecular Medicine, University of Edinburgh, General Western Hospital, Edinburgh, UK
FASEB J 24:4545-55. 2010..Accordingly, IKK inhibitors may be of value in the prevention and treatment of bone diseases characterized by increased bone loss such as postmenopausal osteoporosis...
Large-scale evidence for the effect of the COLIA1 Sp1 polymorphism on osteoporosis outcomes: the GENOMOS studyStuart H Ralston
Rheumatic Diseases Unit, University of Edinburgh, Western General Hospital Edinburgh, Edinburgh, United Kingdom
PLoS Med 3:e90. 2006....
Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget's disease of boneOmar M E Albagha
Rheumatic Diseases Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, UK
Nat Genet 42:520-4. 2010..09 x 10(-13)) and with rs3018362 on 18q21 near the TNFRSF11A gene (P = 5.27 x 10(-13)). These studies provide new insights into the pathogenesis of PDB and identify OPTN, CSF1 and TNFRSF11A as candidate genes for disease susceptibility...
LRP5 Polymorphisms and response to risedronate treatment in osteoporotic menMarcin Kruk
Molecular Medicine Centre, Institute of Genetics and Molecular Medicine, Western General Hospital, University of Edinburgh, Edinburgh, UK
Calcif Tissue Int 84:171-9. 2009..In conclusion, the LRP5 A1330V polymorphism is associated with hip BMD in osteoporotic men, but allelic variations in LRP5 do not appear to be associated with response to bisphosphonate treatment...
Osteoporosis associated with neutralizing autoantibodies against osteoprotegerinPhilip L Riches
Rheumatic Diseases Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom
N Engl J Med 361:1459-65. 2009....
Beta2-adrenoreceptor ligands regulate osteoclast differentiation in vitro by direct and indirect mechanismsSarah J Aitken
Rheumatic Diseases Unit, University of Edinburgh, Western General Hospital, Edinburgh, UK
Arch Biochem Biophys 482:96-103. 2009....
Genetics and osteoporosisOmar M E Albagha
Rheumatology Section, Molecular Medicine Centre, University of Edinburgh School of Molecular and Clinical Medicine, Western General Hospital, Edinburgh, EH4 2XU, United Kingdom
Rheum Dis Clin North Am 32:659-80. 2006..They could be developed as diagnostic genetic tests or form molecular targets for design of new drugs for the prevention and treatment of osteoporosis and other bone diseases...
Cannabinoids and bone: friend or foe?Aymen I Idris
Molecular Medicine Centre, Western General Hospital, University of Edinburgh, Scotland, UK
Calcif Tissue Int 87:285-97. 2010..These data indicate that cannabinoid receptors and the enzymes responsible for ligand synthesis and breakdown play important roles in bone remodeling and in the pathogenesis of joint disease...
Mutations of SQSTM1 are associated with severity and clinical outcome in paget disease of boneMicaela Rios Visconti
Rheumatic Diseases Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom
J Bone Miner Res 25:2368-73. 2010....
Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptorAymen I Idris
Rheumatic Diseases Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom
Endocrinology 149:5619-26. 2008....
Clinical and biochemical response of TNFRSF11A-mediated early-onset familial Paget disease to bisphosphonate therapyPhilip L Riches
Rheumatic Diseases Unit, Molecular Medicine Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, EH4 2XU, UK
Calcif Tissue Int 83:272-5. 2008..The long-term clinical effects of treatment on the natural history of the bone disease remain uncertain however, and this will require further study...
The nitrosylated flurbiprofen derivative HCT1026 inhibits cytokine-induced signalling through a novel mechanism of actionAymen I Idris
Rheumatic Diseases Unit, Molecular Medicine Centre, University of Edinburgh, General Western Hospital, Edinburgh, UK
Eur J Pharmacol 602:215-22. 2009..As RANKL, TNF and IL1 are all important mediators of inflammation and joint destruction, compounds like HCT1026 could represent a novel class of anti-inflammatory compounds...
Randomized trial of intensive bisphosphonate treatment versus symptomatic management in Paget's disease of boneAnne L Langston
Rheumatic Diseases Unit, Institute of Genetics and Molecular Medicine University of Edinburgh, United Kingdom
J Bone Miner Res 25:20-31. 2010..Neither management strategy had a significant beneficial impact on pain or quality of life (Clinical trial registration number ISRCTN12989577)...
Genetic and environmental determinants of peak bone mass in young men and womenFiona E A McGuigan
Aberdeen University, Scotland, UK
J Bone Miner Res 17:1273-9. 2002....
Pharmacologic inhibitors of IkappaB kinase suppress growth and migration of mammary carcinosarcoma cells in vitro and prevent osteolytic bone metastasis in vivoAymen I Idris
Bone Research Group, Institute of Genetic and Molecular Medicine, University of Edinburgh, General Western Hospital, Edinburgh EH4 2XU, United Kingdom
Mol Cancer Ther 8:2339-47. 2009....
Mechanisms of disease: genetics of Paget's disease of bone and related disordersAnna Daroszewska
University of Edinburgh, UK
Nat Clin Pract Rheumatol 2:270-7. 2006....
A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget's disease-like disorder in miceAnna Daroszewska
Rheumatic Diseases Unit, University of Edinburgh, Edinburgh, UK
Hum Mol Genet 20:2734-44. 2011..These studies demonstrate that SQSTM1 mutations can cause a PDB-like skeletal disorder in the absence of an additional trigger and provide a new disease model for PDB...
Advances in the molecular pharmacology and therapeutics of bone disease and International Symposium on Paget's Disease July 10-14, 2007 St. Catherine's College, Oxford, UKStuart H Ralston
Department of Medicine, University of Edinburgh, UK
Bone 41:1059-62. 2007
ABD56 causes osteoclast apoptosis by inhibiting the NFkappaB and ERK pathwaysAymen I Idris
Rheumatic Diseases Unit, Molecular Medicine Centre, University of Edinburgh, General Western Hospital, Edinburgh, EH4 2XU, UK
Biochem Biophys Res Commun 371:94-8. 2008....
Recent insights into the pathogenesis of hyperuricaemia and goutPhilip L Riches
Rheumatic Diseases Unit, University of Edinburgh, Edinburgh EH4 2XU, UK
Hum Mol Genet 18:R177-84. 2009....
Genetic control of susceptibility to osteoporosisStuart H Ralston
Department of Medicine and Therapeutics, University of Aberdeen Medical School, Foresterhill, Aberdeen AB25 2ZD, Scotland, UK
J Clin Endocrinol Metab 87:2460-6. 2002....
Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitroAymen I Idris
Rheumatic Diseases Unit, Molecular Medicine Centre, University of Edinburgh, General Western Hospital, Edinburgh EH4 2XU, UK
Calcif Tissue Int 82:191-201. 2008..This raises the possibility that inhibition of bone formation by bisphosphonates may be due in part to a direct inhibitory effect on cells of the osteoblast lineage...
Contribution of genetic factors to the pathogenesis of Paget's disease of bone and related disordersGavin J A Lucas
Rheumatic Diseases Unit, Molecular Medicine Centre, University of Edinburgh, Edinburgh, United Kingdom
J Bone Miner Res 21:P31-7. 2006..In light of the molecular defects that have been identified thus far, it seems likely that these genes will also be involved in the RANK-NF-kappaB signaling pathway or its interactions with the ubiquitin-proteasome system...
Identification of a major locus for Paget's disease on chromosome 10p13 in families of British descentGavin Ja Lucas
Rheumatic Diseases Unit, University of Edinburgh, Edinburgh, United Kingdom
J Bone Miner Res 23:58-63. 2008..A major susceptibility locus for PDB was identified on chromosome 10p13 by a genome-wide linkage scan in families of British descent, which accounted for the vast majority of cases not caused by SQSTM1 mutations...
SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and goutVeronique Vitart
MRC Human Genetics Unit, Western General Hospital, Edinburgh EH4 2XU, UK
Nat Genet 40:437-42. 2008..SLC2A9 is a known fructose transporter, and we now show that it has strong uric acid transport activity in Xenopus laevis oocytes...
Regulation of bone mass and bone turnover by neuronal nitric oxide synthaseRobert J van't Hof
Bone Research Group, Institute of Medical Sciences, Department of Medicine and Therapeutics, Foresterhill, Aberdeen AB25 2ZD, United Kingdom
Endocrinology 145:5068-74. 2004..The low level of nNOS expression in bone and the in vitro behavior of nNOS KO bone cells indicate that these actions are indirect and possibly mediated by a neurogenic relay...
Linkage disequilibrium between polymorphisms in the human TNFRSF1B gene and their association with bone mass in perimenopausal womenOmar M E Albagha
Department of Medicine and Therapeutics, University of Aberdeen, Foresterhill, Aberdeen, UK
Hum Mol Genet 11:2289-95. 2002..In summary, our work supports the view that allelic variation in the 3'UTR of TNFRSF1B gene contributes to the genetic regulation of bone mass, with effects that are specific for femoral neck BMD...
Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women: a meta-analysisJohn P A Ioannidis
Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Greece
J Bone Miner Res 17:2048-60. 2002..In summary, we have found that XX homozygotes may have higher BMD and also a decreased risk of fractures when compared with carriers of the x allele, whereas the PvuII polymorphism is not associated with either BMD or fracture risk...
Genetic determinants of susceptibility to osteoporosisOmar M E Albagha
Department of Medicine and Therapeutics, University of Aberdeen Medical School, Aberdeen AB25 2ZD, UK
Endocrinol Metab Clin North Am 32:65-81, vi. 2003....
Association between TNFRSF1B polymorphisms and bone mineral density, bone loss and fracturePaul N Tasker
Department of Medicine and Therapeutics, University of Aberdeen, Foresterhill, AB25 2ZD, Aberdeen, UK
Osteoporos Int 15:903-8. 2004....
Genotype-phenotype relationship in human ATP6i-dependent autosomal recessive osteopetrosisAnna Taranta
Istituto Dermopatico dell'Immacolata, Rome, Italy
Am J Pathol 162:57-68. 2003..Bone marrow transplantation was successful in all patients, and posttransplant osteoclasts showed rescue of a3 subunit immunoreactivity...
Characterization of common genetic variants in cathepsin K and testing for association with bone mineral density in a large cohort of perimenopausal women from ScotlandFabienne S Giraudeau
Department of Discovery Genetics, GlaxoSmithKline Research and Development, New Frontiers Science Park, Harlow, United Kingdom
J Bone Miner Res 19:31-41. 2004..We present a thorough analysis of common CTSK polymorphisms and genetic relatedness among CTSK haplotypes...
Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomesJohn P A Ioannidis
Clinical and Molecular Epidemiology Unit, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece
JAMA 292:2105-14. 2004..Estrogen receptor alpha (ESR1) is a candidate gene for osteoporosis, but previous studies of ESR1 polymorphisms in this field were hampered by small sample size, lack of standardization, and inconclusive results...
Polymorphisms in the P450 c17 (17-hydroxylase/17,20-Lyase) and P450 c19 (aromatase) genes: association with serum sex steroid concentrations and bone mineral density in postmenopausal womenJohn Somner
Department of Chemical Pathology, St Thomas Hospital, London, SE1 7EH United Kingdom
J Clin Endocrinol Metab 89:344-51. 2004..012). Subjects with the CC genotype had significantly lower BMD (mean +/- SD: TT, 0.7 +/- 0.16; CC, 0.6 +/- 0.08 g/cm(2); P = 0.006). In conclusion, both CYP 17 and CYP 19 are candidate genes for osteoporosis in postmenopausal women...
Genetic determinants of susceptibility to osteoporosisStuart H Ralston
University of Aberdeen Medical School, Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen AB25 2ZD, UK
Curr Opin Pharmacol 3:286-90. 2003..Information from these studies is being used to design new drugs for osteoporosis and to develop genetic markers for fracture risk assessment...
Influence of LRP5 polymorphisms on normal variation in BMDM Audrey Koay
Institute of Musculoskeletal Sciences, University of Oxford, The Botnar Research Centre, Nuffield Orthopaedic Centre, Headington, Oxford, UK
J Bone Miner Res 19:1619-27. 2004....
A mutation affecting the latency-associated peptide of TGFbeta1 in Camurati-Engelmann disease enhances osteoclast formation in vitroNeil W A McGowan
Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen AB25 2ZD, United Kingdom
J Clin Endocrinol Metab 88:3321-6. 2003..The activation of osteoclast activity noted here is consistent with clinical reports that have shown biochemical evidence of increased bone resorption as well as bone formation in CED...
The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysisAndre G Uitterlinden
Erasmus MC, Rotterdam, The Netherlands
Ann Intern Med 145:255-64. 2006..Polymorphisms of the vitamin D receptor (VDR) gene have been implicated in the genetic regulation of bone mineral density (BMD). However, the clinical impact of these variants remains unclear...
Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptorsAymen I Idris
Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK
Nat Med 11:774-9. 2005....
Large-scale population-based study shows no association between common polymorphisms of the TGFB1 gene and BMD in womenFiona E A McGuigan
Department of Medicine and Therapeutics, University of Aberdeen, UK
J Bone Miner Res 22:195-202. 2007..We studied five common polymorphisms of TGFB1 in relation to osteoporosis-related phenotypes in a population-based cohort of 2975 British women, but found no significant association with bone mass, bone loss, bone markers, or fracture...
Development and characterization of biphenylsulfonamides as novel inhibitors of bone resorptionIain R Greig
School of Medicine, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK
J Med Chem 49:7487-92. 2006..In conclusion, biphenylsulfonamides like 55 form a new class of potent antiresorptive agents with possible therapeutic use in diseases characterized by increased bone resorption...
Ubiquitin-associated domain mutations of SQSTM1 in Paget's disease of bone: evidence for a founder effect in patients of British descentGavin J A Lucas
Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, United Kingdom
J Bone Miner Res 20:227-31. 2005..Here we show that the most common disease-causing mutation (P392L) is carried on a shared haplotype, consistent with a founder effect and a common ancestral origin...
Meta-analysis of genome-wide scans provides evidence for sex- and site-specific regulation of bone massJohn P A Ioannidis
Department of Hygiene and Epidemology, University of Ioannina School of Medicine, Ioannina, Greece
J Bone Miner Res 22:173-83. 2007..Evidence was gained to suggest that several chromosomal loci regulate BMD in a site-specific and sex-specific manner...
Bone densitometry and bone biopsyStuart H Ralston
Bone Research Group, Institute of Medical Sciences, University of Aberdeen Medical School, Foresterhill, Aberdeen AB25 2ZD, UK
Best Pract Res Clin Rheumatol 19:487-501. 2005..Under these circumstances it is an invaluable investigation that can be used to differentiate infiltrative disorders from primary abnormalities of osteoblast or osteoclast function...
Evolution of understanding of genetics of Paget's disease of bone and related diseasesShinjiro Takata
Department of Orthopedics, The University of Tokushima School of Medicine, 3-18-15 Kuramoto-cho, Tokushima, Japan
J Bone Miner Metab 22:519-23. 2004
PTHR1 polymorphisms influence BMD variation through effects on the growing skeletonCarles Vilariño-Güell
Institute of Musculoskeletal Sciences, Botnar Research Centre, Nuffield Orthopaedic Centre, University of Oxford, Headington, Oxford, UK
Calcif Tissue Int 81:270-8. 2007..006) and total body less head BMD (P = 0.02), corrected for age and gender, confirming the family findings. These findings suggest a role for PTHR1 variation in determining peak BMD...
Vitamin K1 intake is associated with higher bone mineral density and reduced bone resorption in early postmenopausal Scottish women: no evidence of gene-nutrient interaction with apolipoprotein E polymorphismsHelen M Macdonald
Department of Medicine and Therapeutics, University of Aberdeen, Foresterhill, Aberdeen, United Kingdom
Am J Clin Nutr 87:1513-20. 2008..Polymorphisms in the apolipoprotein E (APOE) gene are associated with fracture risk, and a potential mechanism is through vitamin K transport...
Evaluation of the role of Valosin-containing protein in the pathogenesis of familial and sporadic Paget's disease of boneGavin J A Lucas
Department of Medicine and Therapeutics, University of Aberdeen, UK
Bone 38:280-5. 2006..Genetic variation in VCP does not appear to be a common cause of familial or sporadic PDB in the absence of myopathy and dementia...
Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosisJoyce B J van Meurs
Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands
JAMA 299:1277-90. 2008..Mutations in the low-density lipoprotein receptor-related protein 5 (LRP5) gene cause rare syndromes characterized by altered bone mineral density (BMD). More common LRP5 variants may affect osteoporosis risk in the general population...
Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS studyBente L Langdahl
Department of Endocrinology, Aarhus University Hospital, Aarhus, Denmark
Bone 42:969-81. 2008....
ER stress-mediated apoptosis in a new mouse model of osteogenesis imperfectaThomas S Lisse
Institute of Experimental Genetics, Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany
PLoS Genet 4:e7. 2008....
Polymorphisms of the CLCN7 gene are associated with BMD in womenUlrika Pettersson
Bone Research Group, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, United Kingdom
J Bone Miner Res 20:1960-7. 2005..Our study adds to accumulating evidence that shows that common allelic variants in monogenic bone disease genes often contribute to BMD regulation in normal subjects...
Interspecies synteny mapping identifies a quantitative trait locus for bone mineral density on human chromosome Xp22Claire A Parsons
Bone Research Group, University of Aberdeen, UK
Hum Mol Genet 14:3141-8. 2005..002). Our study illustrates that interspecies synteny can be used to identify and refine QTL for complex traits and represents the first example where a human QTL for BMD regulation has been mapped using this approach...
The pro and con of measles virus in Paget's disease: conBert K Rima
J Bone Miner Res 17:2290-2; author reply 2293. 2002
Identification of biphenylcarboxylic acid derivatives as a novel class of bone resorption inhibitorsAymen I Idris
Bone Research Group, Department of Medicine and Therapeutics, Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK
J Bone Miner Res 19:1651-60. 2004....
Genetics of Paget's disease of boneAnna Daroszewska
Institute of Medical Sciences, University of Aberdeen Medical School, Aberdeen AB25 2ZD, UK
Clin Sci (Lond) 109:257-63. 2005....
Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's diseaseLynne J Hocking
Department of Medicine and Therapeutics, University of Aberdeen, UK
Hum Mol Genet 11:2735-9. 2002..0001). These studies confirm that mutations affecting the ubiquitin-binding domain of SQSTM1 are a common cause of familial and sporadic Paget's disease of bone...
Genetics of osteoporosisHuilin Jin
University of Aberdeen Medical School, Department of Medicine and Therapeutics, University of Aberdeen, AB25 2ZD, UK
Curr Rheumatol Rep 7:66-70. 2005....
New developments in the search for genetic determinants of osteoarthritisStuart H Ralston
Osteoarthritis Cartilage 15:117-9. 2007
Phenotypic characterization of early onset Paget's disease of bone caused by a 27-bp duplication in the TNFRSF11A geneKiyoshi Nakatsuka
Department of Endocrinology, Metabolism and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan
J Bone Miner Res 18:1381-5. 2003..A particularly striking feature was involvement of the mandible and maxilla, but it remains to be seen if this is a specific feature of the 75dup27 mutation until further kindreds with this mutation are reported...
Identification of sex-specific associations between polymorphisms of the osteoprotegerin gene, TNFRSF11B, and Paget's disease of boneGreet Beyens
Department of Medical Genetics, University and University Hospital of Antwerp, Antwerp, Belgium
J Bone Miner Res 22:1062-71. 2007..We observed no association in men, but a highly significant association was found in women, and this was confirmed in a population from the United Kingdom...
Novel UBA domain mutations of SQSTM1 in Paget's disease of bone: genotype phenotype correlation, functional analysis, and structural consequencesLynne J Hocking
Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, United Kingdom
J Bone Miner Res 19:1122-7. 2004..Functional and structural analysis showed that disease severity was related to the type of mutation but was unrelated to the polyubiquitin-binding properties of the mutant UBA domain peptides...
RUNX2 alleles associated with BMD in Scottish women; interaction of RUNX2 alleles with menopausal status and body mass indexTanya Vaughan
School of Health Science, Griffith University Gold Coast Campus, 4215 Queensland, Australia
Bone 34:1029-36. 2004..Glutamine variants and an alanine insertion were identified within the group. These data suggest that the RUNX2 alleles are associated with BMD in a menopause- and weight-dependent manner...
Susceptibility to Paget's disease of bone is influenced by a common polymorphic variant of osteoprotegerinAnna Daroszewska
Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen AB25 2ZD, UK
J Bone Miner Res 19:1506-11. 2004..We found that the G1181 allele of TNFRSF11B, encoding lysine at codon 3 of the OPG protein, predisposes to both sporadic and familial PDB...
Transforming growth factor-beta 1 mutations in Camurati-Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant proteinKatrien Janssens
Department of Medical Genetics, University of Antwerp, 2610 Antwerp, Belgium
J Biol Chem 278:7718-24. 2003..Our data indicate that the mutations in the signal peptide and latency-associated peptide facilitate TGF-beta1 signaling, thus causing Camurati-Engelmann disease...
